Ameriprise’s MediciNova MNOV Stock Holding History

Ameriprise’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,300	Closed	-$42K	–	4015
2022 Q3	$42K	Sell	19,300 -6,200	-24%	-$14.4K	﹤0.01%	3898
2022 Q2	$65K	Sell	25,500 -1,700	-6%	-$4.44K	﹤0.01%	3815
2022 Q1	$73K	Hold	27,200	–	–	﹤0.01%	3866
2021 Q4	$73K	Sell	27,200 -7,500	-22%	-$25.1K	﹤0.01%	3891
2021 Q3	$132K	Buy	34,700 +1,300	+4%	+$4.94K	﹤0.01%	3754
2021 Q2	$142K	Buy	33,400 +2,700	+9%	+$11.6K	﹤0.01%	3791
2021 Q1	$155K	Buy	30,700 +250	+0.8%	+$1.45K	﹤0.01%	3736
2020 Q4	$159K	Buy	+30,450	New	+$174K	﹤0.01%	3650

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ameriprise's MNOV Position: Q4 2022 in Review

Ameriprise sold out of MediciNova (MNOV) in Q4 2022, closing a stake of 19,300 shares — an estimated $42K sold.

Ameriprise first reported a position in MNOV in Q4 2020 and held it in 8 quarters. The position peaked at $159K in Q4 2020. 41 funds tracked by Wall St. Rank hold MNOV as of Q4 2022.

Ameriprise reported no remaining MediciNova position as of Q4 2022 after selling out during the quarter.
Ameriprise sold 19,300 MediciNova shares in Q4 2022, an estimated $42K.
Ameriprise first reported a position in MediciNova in Q4 2020 and held it in 8 quarters.
Ameriprise's MediciNova position peaked at $159K in Q4 2020.
41 funds tracked by Wall St. Rank held MediciNova as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.